Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Research & Development: 2020-2025

Historic Research & Development for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $83.0 million.

  • IDEAYA Biosciences' Research & Development rose 45.21% to $83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.9 million, marking a year-over-year increase of 73.27%. This contributed to the annual value of $294.7 million for FY2024, which is 127.53% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Research & Development stood at $83.0 million, which was down 40.80% from $140.2 million recorded in Q4 2024.
  • Over the past 5 years, IDEAYA Biosciences' Research & Development peaked at $140.2 million during Q4 2024, and registered a low of $11.6 million during Q1 2021.
  • Moreover, its 3-year median value for Research & Development was $42.8 million (2024), whereas its average is $56.4 million.
  • Data for IDEAYA Biosciences' Research & Development shows a peak YoY spiked of 261.58% (in 2024) over the last 5 years.
  • Over the past 5 years, IDEAYA Biosciences' Research & Development (Quarterly) stood at $16.1 million in 2021, then spiked by 53.40% to $24.7 million in 2022, then skyrocketed by 56.88% to $38.8 million in 2023, then spiked by 261.58% to $140.2 million in 2024, then soared by 45.21% to $83.0 million in 2025.
  • Its Research & Development was $83.0 million in Q3 2025, compared to $140.2 million in Q4 2024 and $57.2 million in Q3 2024.